Boehringer Ingelheim
Boehringer Ingelheim is a biopharmaceutical company focused on human and animal health. As one of the industry’s largest investors in research and development, we focus on developing innovative therapies in areas of high unmet medical need. Since our founding in 1885, we at Boehringer have taken a long-term perspective, integrating sustainability into all our activities. More than 53,500 employees serve more than 130 markets to build a healthier, more sustainable, and more equitable future.